CLINICAL_TRIALS
trial_result
· 2013-11-13
Clinical Trial Update: Nefazodone in the Treatment of Social Phobia [Phase 4]
Summary
A Phase 4 study evaluating nefazodone for social anxiety disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Social Anxiety Disorder (SAD) | Phase 4 | Status: COMPLETED